Grimes & Company’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.41M Buy
67,169
+3,048
+5% +$293K 0.14% 104
2026
Q1
$6.64M Buy
64,121
+24,577
+62% +$2.79M 0.18% 96
2025
Q4
$3.99M Sell
39,544
-26,924
-41% -$2.92M 0.1% 127
2025
Q3
$8.2M Sell
66,468
-2,411
-4% -$299K 0.2% 90
2025
Q2
$8.27M Buy
68,879
+9,615
+16% +$1.28M 0.23% 91
2025
Q1
$8.73M Buy
+59,264
New +$9.05M 0.27% 85

Other funds holding CLX

Grimes & Company's CLX Position: Q2 2026 in Review

Grimes & Company increased its Clorox (CLX) stake by 4.8% in Q2 2026, buying an estimated $293K and bringing the position to 67,169 shares worth $6.41M. The position accounts for 0.14% of the portfolio, ranked #104.

Grimes & Company first reported a position in CLX in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.73M in Q1 2025. 434 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Grimes & Company held 67,169 shares of Clorox worth $6.41M as of Q2 2026.
  • Grimes & Company bought 3,048 Clorox shares in Q2 2026, an estimated $293K.
  • Clorox made up 0.14% of Grimes & Company's portfolio in Q2 2026, its #104 holding.
  • Grimes & Company first reported a position in Clorox in Q1 2025 and has held it in 6 quarters since.
  • Grimes & Company's Clorox position peaked at $8.73M in Q1 2025.
  • 434 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.